2022 Notices

Stay connected


September 28, 2022
Deadline extensions to support those affected by hurricane Fiona in Atlantic Canada

CIHR is aware that hurricane Fiona has impacted many of our colleagues in Atlantic Canada. If you were impacted by the hurricane and were intending to apply to one of the competitions listed below, we will extend the application deadline for you by request.

  • Fellowship : CIHR Fellowship
  • Operating Grant : Data Analysis Using Existing Databases and Cohorts (2022)
  • Operating Grant: Psilocybin-assisted Psychotherapy
  • Team Grant : Diabetes Prevention and Treatment in Indigenous Communities: Resilience and Wellness
  • Catalyst Grant : Policy Research for Health System Transformation
  • Team Grant : Sleep Research Consortium

Please reach out to the CIHR Contact Centre should you require additional time to submit your application at:

CIHR Contact Centre
Tel: 613-954-1968
Toll free: 1-888-603-4178


June 21, 2022
Transcripts for the fall 2022 scholarships and fellowships competitions

Canada’s three granting agencies—the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Social Sciences and Humanities Research Council of Canada (SSHRC)—acknowledge that the widespread disruption caused by the COVID-19 pandemic may hinder the ability of some institutions to provide applicants with official and up-to-date transcripts in advance of the deadline date, particularly at institutions which do not currently provide official electronic versions of these documents. Therefore, for the fall 2022 scholarships and fellowships competitions, the agencies will continue to accept unofficial transcripts if official transcripts cannot be obtained.

Applicants should contact their faculty of graduate studies to determine whether an official transcript can be provided. Submission of an application will continue to serve as a formal attestation that the applicant has provided true, complete, and accurate information in the application and its related documents.

June 16, 2022
COVID-19 exceptions to Tri-agency post-award regulations for trainees

Training award recipients (master's, doctoral, and postdoctoral) may defer the start date of their award, or request an unpaid interruption, normally in four-month increments, for reasons related to the COVID-19 pandemic. For master’s and doctoral award holders, this can be adjusted to align with the next available start date (September 1, 2022, or January 1, 2023).

The agencies will continue to support training award holders who, given the challenges posed by the COVID-19 situation, can only devote part-time hours to their research. They may continue to hold their awards and will be paid at the full amount. The amount will not be prorated, and the end date of the award will remain unchanged.

For the period where travel is significantly limited due to the COVID pandemic, training award recipients may choose to hold their award remotely while pursuing their research training, so long as the following conditions are met:

  • Students must be registered at the host institution during the period when travel restrictions/institution closures are in place. Postdoctoral fellows must be actively engaged in research.
  • This arrangement must have the support from the supervisor.


February 9, 2022
CIHR introduces new Policy Guide with requirements for the registration and disclosure of results from clinical trials

As a signatory of the World Health Organization’s Joint Statement on Public Disclosure of Results from Clinical Trials, CIHR is committed to advancing open science, research excellence, and greater transparency in clinical trials. To that end, CIHR has introduced a Policy Guide with new requirements for the registration and public disclosure of the results of clinical trials.

Nominated Principal Investigators receiving CIHR grant funds for clinical trial research on or after January 1, 2022 must comply with the following practices to remain eligible for new CIHR funding:

  • Clinical trials must be registered in a publicly available, free-to-access, searchable clinical trial registry complying with the WHO’s international agreed standards before the researcher meets with the first study participant.
  • New Public disclosure of results must be done within a mandated time frame:
    • Publications describing clinical trial results must be open access from the date of publication.
    • Summary results must be publicly available within 12 months from the last visit of the last participant (for collection of data on the primary outcome).
  • New All study publications must include the registration number/Trial ID (to be specified in the article summary/abstract).

We invite you to read the Policy Guide and consult the Frequently Asked Questions to learn more.

Date modified: